Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections

Journal of Hospital Infection

Volumn 70, Issue SUPPL. 2, 2008, Pages 15-20

  Dohmen, P M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antibiotic prophylaxis; Antibiotic resistance; Microbial sealant; Skin bacteria; Wound contamination

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFOXITIN; CEPHALOSPORIN; CHLORHEXIDINE; CLINDAMYCIN; CYANOACRYLATE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; INTEGUSEAL; LINEZOLID; METRONIDAZOLE; POLYPEPTIDE ANTIBIOTIC AGENT; POVIDONE IODINE; SEALANT; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL EFFECTIVENESS; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG HALF LIFE; DRUG MECHANISM; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; INFECTION RISK; MORBIDITY; MORTALITY; OPTIMAL DRUG DOSE; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE CARE; REPEATED DRUG DOSE; RISK ASSESSMENT; RISK REDUCTION; SINGLE DRUG DOSE; SKIN FLORA; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; TREATMENT DURATION; WOUND INFECTION;

EID: 55949089227     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(08)60019-5     Document Type: Article

References (44)

1. Edwards P.S., Lipp A., and Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev (2004) CD003949.
2. Homer-Vanniasinkam S. Surgical site and vascular infections: treatment and prophylaxis. Int J Infect Dis 11 Suppl 1 (2007) S17-S22
3. Leaper D.J., van Goor H., Reilly J., et al. Surgical site infection a European perspective of incidence and economic burden. Int Wound J 1 (2004) 247-273
4. Alfonso J.L., Pereperez S.B., Canoves J.M., et al. Are we really seeing the total costs of surgical site infections? A Spanish study. Wound Repair Regen 15 (2007) 474-481
5. Nagachinta T., Stephens M., Reitz B., and Polk B.F. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 156 (1987) 967-973
6. Ottino G., De Paulis R., Pansini S., et al. Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg 44 (1987) 173-179
7. Demmy T.L., Park S.B., Liebler G.A., et al. Recent experience with major sternal wound complications. Ann Thorac Surg 49 (1990) 458-462
8. Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., and Emori T.G. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13 (1992) 606-608
9. Farinas M.C., Gald Peralta F., Bernal J.M., et al. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 20 (1995) 272-279
10. Milano C.A., Kesler K., Archibald N., Sexton D.J., and Jones R.H. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation 92 (1995) 2245-2251
11. Parisian Mediastinitis Study Group. Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. J Thorac Cardiovasc Surg 111 (1996) 1200-12007
12. Horan T.C., and Emori T.G. Definitions of key terms used in the NNIS System. Am J Infect Control 25 (1997) 112-116
13. Munoz P., Menasalvas A., Bernaldo de Quiros J.C., et al. Postsurgical mediastinitis: a case-control study. Clin Infect Dis 25 (1997) 1060-1064
14. Bitkover C.Y., and Gårdlund B. Mediastinitis after cardiovascular operations: a case-control study of risk factors. Ann Thorac Surg 65 (1998) 36-40
15. McConkey S.J., L'Ecuyer P.B., Murphy D.M., et al. Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 20 (1999) 533-538
16. Wang F.D., and Chang C.H. Risk factors of deep sternal wound infections in coronary artery bypass graft surgery. J Cardiovasc Surg (Torino) 41 (2000) 709-713
17. Russo P.L., and Spelman D.W. A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 23 (2002) 372-376
18. Abboud C.S., Wey S.B., and Baltar V.T. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg 77 (2004) 676-683
19. Harrington G., Russo P., Spelman D., et al. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 25 (2004) 472-476
20. Kaye K.S., Sloane R., Sexton D.J., and Schmader K.A. Risk factors for surgical site infections in older people. J Am Geriatr Soc 54 (2006) 391-396
21. Segers P., de Jong A.P., Kloek J.J., Spanjaard L., and de Mol B.A. Risk control of surgical site infection after cardiothoracic surgery. J Hosp Infect 62 (2006) 437-445
22. Patel A.N., Henry A.C., Hunnicutt C., Cockerham C.A., Willey B., and Urschel Jr. H.C. Endoscopic radial artery harvesting is better than the open technique. Ann Thorac Surg 78 (2004) 149-153 discussion 149-153.
23. Lai T., Babb Y., Ning Q., et al. The transition from open to endoscopic saphenous vein harvesting and its clinical impact: The Texas Heart Institute experience. Tex Heart Inst J 33 (2006) 316-320
24. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R., and the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 27 (1999) 97-134
25. Edwards F.H., Engelman R.M., Houck P., Shahian D.M., and Bridges C.R. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg 81 (2006) 397-404
26. Engelman R., Shahian D., and Shemin R. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg 83 (2007) 1569-1576
27. Houang E.T., and Ahmet Z. Intraoperative wound contamination during abdominal hysterectomy. J Hosp Infect 19 (1991) 181-189
28. Barie P.S., and Eachempati S.R. Surgical site infections. Surg Clin N Am 85 (2005) 1115-1135 viii ix.
29. Wilson M.A. Skin and soft-tissue infections: impact of resistant gram-positive bacteria. Am J Surg 186/5A (2003) 35S-41S
30. Fry D.E. The Surgical Infection Prevention project: processes, outcomes, and future impact. Surg Infect 7 Suppl 3 (2006) S17-S26
31. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004) 1706-1715
32. Dohmen P. Influence of skin flora and preventive measures on surgical site infection during cardiac surgery. Surg Infect 7 Suppl 1 (2006) S13-S17
33. Pong A., and Bradley J.S. Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis 15 (2004) 21-29
34. Howard D.H., Scott II R.D., Packard R., and Jones D. The global impact of antibiotic resistance. The global impact of drug resistance. Clin Infect Dis 36 Suppl 1 (2003) S4-S10
35. Berry A.R., Watt B., Goldacre M.J., Thomson J.W., and McNair T.J. A comparison of the use of povidone-iodine and chlorhexidine in the prophylaxis of postoperative wound infection. J Hosp Infect 3 (1982) 55-63
36. Grabsch E.A., Mitchell D.J., Hooper J., and Turnidge J.D. In-use efficacy of a chlorhexidine in alcohol surgical rub: a comparative study. Aust NZ J Surg 74 (2004) 769-772
37. Webster J., and Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev (2006) CD004985.
38. Fairclough J.A., Johnson D., and Mackie I. The prevention of wound contamination by skin organisms by the pre-operative application of an iodophor impregnated plastic adhesive drape. J Int Med Res 14 (1986) 105-109
39. Yoshimura Y., Kubo S., Hirohashi K., et al. Plastic iodophor drape during liver surgery operative use of the iodophor-impregnated adhesive drape to prevent wound infection during high risk surgery. World J Surg 27 (2003) 685-688
40. Dohmen P.M., Gabbieri D., Dorgham O., Linneweber J., and Konertz W. Clinical investigation of InteguSeal in coronary artery bypass procedures: A matched case-control study. Cardiovasc Sci Forum 3 1 (2008) 9-16
41. Dohmen P.M., and Konertz W. A review of current strategies to reduce intraoperative bacterial contamination of surgical wounds. GMS Krankenhaushyg Interdiszip 2 2 (2007) Doc27.
42. Kurz A., Sessler D.I., Lenhardt R., et al. Perioperative normothermia to reduce the incidence of surgical wound infection and shorten hospitalization. N Engl J Med 334 (1996) 1209-1215
43. Greif R., Akça O., Horn E.P., Kurz A., and Sessler D.I. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 342 (2000) 161-167
44. Pittas A.G., Siegel R.D., and Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Int Med 164 (2004) 2005-2011